Measurement of success: parameters of efficacy.

Por de Mulder, P. H.
Publicado em 1992

Adult-onset Still's disease: destructive distal interphalangeal arthritis associated with transient capsular calcification

Por De Mulder, P. H. M., Van De Putte, L. B. A.
Publicado em 1982

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer

Por Span, P N, Bussink, J, De Mulder, P H, Sweep, F C G J
Publicado em 2007

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Geni...

Por De Mulder, P. H., Oosterhof, G., Bouffioux, C., van Oosterom, A. T., Vermeylen, K., Sylvester, R.
Publicado em 1995

Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.

Por Verweij, J., Wanders, J., Gil, T., Schöffski, P., Catimel, G., te Velde, A., de Mulder, P. H.
Publicado em 1996

Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's disease.

Por de Mulder, P H, van Rennes, H, Mier, P D, Bergers, M, de Pauw, B E, Haanen, C
Publicado em 1983

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

Por Punt, C. J., van Herpen, C. M., Jansen, R. L., Vreugdenhil, G., Muller, E. W., de Mulder, P. H.
Publicado em 1997

Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.

Por Kruit, W. H., Punt, C. J., Goey, S. H., de Mulder, P. H., Gratama, J. W., Eggermont, A. M., Bolhuis, R. L., Stoter, G.
Publicado em 1996

Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients

Por Haicheur, N, Escudier, B, Dorval, T, Negrier, S, De Mulder, P H M, Dupuy, J M, Novick, D, Guillot, T, Wolf, S, Pouillart, P, Fridman, W H, Tartour, E
Publicado em 2000

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Por Punt, C. J., Voest, E. E., Tueni, E., Van Oosterom, A. T., Backx, A., De Mulder, P. H., Hecquet, B., Lucas, C., Gerard, B., Bleiberg, H.
Publicado em 1997

Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity.

Por van Klaveren, R J, de Mulder, P H, Boerbooms, A M, van de Kaa, C A, van Haelst, U J, Wagener, D J, Hafkenscheid, J C
Publicado em 1990

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tra...

Por de Wit, R., Stoter, G., Sleijfer, D. T., Kaye, S. B., de Mulder, P. H., ten Bokkel Huinink, W. W., Spaander, P. J., de Pauw, M., Sylvester, R.
Publicado em 1995

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)

Por Fosså, S D, Paluchowska, B, Horwich, A, Kaiser, G, de Mulder, P H M, Koriakine, O, van Oosterom, A T, de Prijck, L, Collette, L, de Wit, R
Publicado em 2005

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.

Por de Wit, R., Collette, L., Sylvester, R., de Mulder, P. H., Sleijfer, D. T., ten Bokkel Huinink, W. W., Kaye, S. B., van Oosterom, A. T., Boven, E., Stoter, G.
Publicado em 1998

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial.

Por Stouthard, J. M., Goey, H., de Vries, E. G., de Mulder, P. H., Groenewegen, A., Pronk, L., Stoter, G., Sauerwein, H. P., Bakker, P. J., Veenhof, C. H.
Publicado em 1996

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous...

Por de Wit, R., Sylvester, R., Tsitsa, C., de Mulder, P. H., Sleyfer, D. T., ten Bokkel Huinink, W. W., Kaye, S. B., van Oosterom, A. T., Boven, E., Vermeylen, K., Stoter, G.
Publicado em 1997